Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)

NCT07290244 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Open Angle Glaucoma (OAG)
NAION( Non-arteritic Anterior Ischemic Optic Neuropathy)

Interventions

GENETIC: ER-100 epigenetic therapy

Sponsor

Life Biosciences Inc.